D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
SGMT holding history
Sagimet Biosciences Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SGMT overviewAll 13F holders of SGMTFull Q2 2026 holdings
- Shares (Q2 2026)
- 22,177
- Value
- $171.4K
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 22,177 | $171.4K | <0.1% | −389,393−94.6% | Reduced | Holders |
| Q1 2026 | 411,570 | $2.15M | <0.1% | −73,926−15.2% | Reduced | Holders |
| Q4 2025 | 485,496 | $2.87M | <0.1% | −215,745−30.8% | Reduced | Holders |
| Q3 2025 | 701,241 | $4.81M | <0.1% | +557,393+387.5% | Added | Holders |
| Q2 2025 | 143,848 | $1.10M | <0.1% | +143,848 | New | Holders |